| Schedule of profit or loss and total assets for each reportable segment |
Nine months Ended May 31, 2025 | | IP Licensing | | | B2B Product | | | R&D | | | Corporate | | | Consolidated Total | | Revenue | | $ | 522,000 | | | $ | 9,923 | | | $ | - | | | $ | - | | | $ | 531,923 | | Cost of goods sold | | | - | | | | (2,720 | ) | | | - | | | | - | | | | (2,720 | ) | Operating expenses | | | (10,924 | ) | | | (10,116 | ) | | | (6,356,636 | ) | | | (3,343,667 | ) | | | (9,721,343 | ) | Other Income (Expense) | | | - | | | | - | | | | - | | | | (22,066 | ) | | | (22,066 | ) | Segment Income (Loss) | | $ | 511,076 | | | $ | (2,913 | ) | | $ | (6,356,636 | ) | | $ | (3,365,733 | ) | | $ | (9,214,206 | ) | | | | | | | | | | | | | | | | | | | | | | Total assets | | $ | 165,649 | | | $ | 56,656 | | | $ | 513,646 | | | $ | 6,005,415 | | | $ | 6,741,366 | |
Nine Months Ended May 31, 2024 | | IP Licensing | | | B2B Product | | | R&D | | | Corporate | | | Consolidated Total | | Revenue | | $ | 373,990 | | | $ | 5,388 | | | $ | 900 | | | $ | - | | | $ | 380,278 | | Cost of goods sold | | | - | | | | (4,822 | ) | | | - | | | | - | | | | (4,822 | ) | Operating expenses | | | (130 | ) | | | (288 | ) | | | (1,393,359 | ) | | | (2,531,745 | ) | | | (3,925,522 | ) | Other Income (Expense) | | | - | | | | - | | | | - | | | | (72,017 | ) | | | (72,017 | ) | Segment Income (Loss) | | $ | 373,860 | | | $ | 278 | | | $ | (1,392,459 | ) | | $ | (2,603,762 | ) | | $ | (3,622,083 | ) | | | | | | | | | | | | | | | | | | | | | | Total assets | | $ | 124,968 | | | $ | 63,573 | | | $ | 475,194 | | | $ | 9,354,702 | | | $ | 10,018,437 | |
|